Polypharmacy in the Elderly: Geriatric Medication Safety

Added:

Appropriate Polypharmacy and the Risk of Undertreatment

While polypharmacy is frequently criticized for increasing the risk of adverse drug events, an alternative perspective emphasizes the clinical necessity of "appropriate polypharmacy" and warns against the dangers of undertreatment in older adults. Elderly patients often present with multiple complex, chronic conditions (multimorbidity). In these cases, taking multiple evidence-based medications is essential to manage symptoms, prevent disease progression, and maintain quality of life. An overzealous focus on reducing pill counts can lead to therapeutic undertreatment—where patients are denied beneficial therapies, such as cardiovascular preventatives, pain management, or osteoporosis treatments, solely due to fear of prescribing. Proponents of this view argue that instead of focusing strictly on the quantity of medications (deprescribing), clinical goals should center on optimized, patient-centered prescribing, recognizing that a high medication burden can be both clinically justified and highly beneficial when managed properly.

Basic pharmacokinetics and pharmacodynamics, specifically how drugs are absorbed, distributed, metabolized, and excreted in the human body.
The physiological changes associated with normal aging, particularly the age-related decline in renal and hepatic clearance.
The concept of multimorbidity, where patients present with multiple co-occurring chronic health conditions.
General definitions of adverse drug reactions (ADRs) and the fundamental mechanisms of drug-drug and drug-disease interactions.
Application of clinical screening tools for inappropriate prescribing, such as the Beers Criteria and the STOPP/START criteria.
The systematic process of 'deprescribing', including tapering protocols and shared decision-making with patients.
Medication reconciliation techniques and the role of interprofessional healthcare teams in managing transition-of-care risks.
Advanced pharmacogenomics and how genetic variations in elderly populations influence drug response and personalized therapy.
45.2K views307likes3:19@medsklOriginal Release: 2016-11-07

Polypharmacy, defined as the use of more than five medications simultaneously, affects approximately one-third of elderly patients who often have multiple chronic conditions; this practice increases the risk of preventable adverse drug reactions (25% of which are preventable), leading to unnecessary hospitalizations and reduced quality of life, primarily due to physiological changes in aging bodies that alter drug distribution, absorption, metabolism, and excretion, along with limited pharmacokinetic data from elderly populations; effective management requires regular medication reviews, vigilance for new symptoms, and deprescribing unnecessary medications to optimize patient outcomes.